News for Industry
Cynata Therapeutics Achieves Progress in Stem Cell Technology (Proactive Investors)
(Madison, Wisconsin) Cynata therapeutics received the Notice of Allowance from the US patent office related to their proprietary Cymerus stem cell technology.
Japanese Man is First to Receive Reprogrammed Stem Cells from Another Person (Nature)
(Hyogo, Japan) Creating induced pluripotent stem (IPS) cells from unrelated donors and using them to regenerate tissue/cure diseases has huge possibilities for the future of healthcare.
Creative Medical Health Inc. Files Patent on Multiple Sclerosis Stem Cell Therapy (Business Wire)
(Phoenix, Arizona) Creative Medical Health filed intellectual property covering the utilization of proprietary mesenchymal stem cell-based products for the treatment of autoimmune diseases.
Using Stem Cells To Grow New Hair (Eureka Alert)
(La Jolla, CA) Pluripotent stem cells from as a new treatment for hair restoration.
BioTime Announces Issuance of 14 New Patents in the Fields of Regenerative Medicine, Stem Cell Technology, and Cancer Therapy (Digital Journal)
(Alameda, CA) BioTime In announcing the issuance of 14 new patents utilizing pluripotent stem cell technology for therapeutic applications in the field of regenerative medicine.
Orgenesis and Pall Corporation Receive $800,000 Grant From BIRD Foundation for Diabetes Research and Development (CNN)
(White Plains, NY) Orgenesis and PALL Corporation received an $800,000 grant from the Israel Binational Industrial Research and Development (BIRD) Foundation for the development of functional insulin producing cells (IPCs is).
Regeneus Ltd Acne Treatment Patent Granted (ABN News Wire)
(Sydney, Australia) Patent granted to Company for the use of stem cell treatment for acne.
Scientist Patents Technology to Advance Stem Cell Therapeutics (Scicasts)
(Piscataway, NJ) A breakthrough in the area of gene expression for stem cell therapeutics.
Tengion Provides Clinical Update and Reports Third Quarter 2014 Financial Results and Cash Position (Globe News Wire)
(Winston-Salme, NC) Tengion Inc reported key clinical data and financial/operating results for the quarter ending on September 30, 2014.